Evidence map›Paper›PMID 31040188›Full record

ReviewJournal of the American Society of Nephrology : JASN2019

Arterial Stiffness in the Heart Disease of CKD.

Luca Zanoli, Paolo Lentini, Marie Briet, Pietro Castellino, Andrew A House, Gerard M London, Lorenzo Malatino, Peter A McCullough, Dimitri P Mikhailidis, Pierre Boutouyrie

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of the American Society of Nephrology : JASN, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 109 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
109citing papers in PubMed, 2 pooled it
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

109 citing papers in PubMed, 2 syntheses or guidelines pooled it, 206 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Serum markers of fibrosis, cardiovascular and all-cause mortality in hemodialysis patients: the AURORA trial.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

49 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 9 institutions in 5 countries.

Luca ZanoliSections of Nephrology and zanoli.rastelli@gmail.com.
Paolo LentiniDivision of Nephrology and Dialysis, St. Bassiano Hospital, Bassano del Grappa, Italy.
Marie BrietInstitut National de la Santé et de la Recherche Médicale U1083, National Center for Scientific Research Joint Research Unit 6214, Centre Hospitalo-Universitaire d'Angers, Université d'Angers, Angers, France.
Pietro CastellinoInternal Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Andrew A HouseDepartment of Medicine, University of Western Ontario, London, Ontario, Canada.
Gerard M LondonInstitut National de la Santé et de la Recherche Médicale U970, Paris, France.
Lorenzo MalatinoInternal Medicine, Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Peter A McCulloughDepartment of Medicine, Baylor University Medical Center, Baylor Heart and Vascular Institute, Baylor Jack and Jane Hamilton Heart and Vascular Hospital, Dallas, Texas.
Dimitri P MikhailidisDepartment of Clinical Biochemistry, University College London, London, UK.
Pierre BoutouyrieInstitut National de la Santé et de la Recherche Médicale U970, Paris, France.
University of Catania · ITBaylor University Medical Center · USDélégation Paris 5 · FRInserm · FROspedale San Bassiano · ITPediatric Nephrology of Alabama · USUniversité d'Angers · FRUniversity College London · GBWestern University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CKD frequently leads to chronic cardiac dysfunction. This complex relationship has been termed as cardiorenal syndrome type 4 or cardio-renal link. Despite numerous studies and reviews focused on the pathophysiology and therapy of this syndrome, the role of arterial stiffness has been frequently overlooked. In this regard, several pathogenic factors, including uremic toxins (

Indexed as

Cause of DeathAgedAge DistributionCardio-Renal SyndromeCardiotonic AgentsCardiovascular DiseasesComorbidityFemaleHumansMaleMiddle AgedPrevalencePrognosisRenal DialysisRenal Insufficiency, ChronicRisk AssessmentCardiotonic Agentsarteries, cardiovascular disease, chronic kidney disease, Chronic inflammation, arteriosclerosis, pulse wave velocity

Identifiers

PMID31040188
PMCPMC6551785
OpenAlexW2943197097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.